This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1k9g
From Proteopedia
(New page: 200px<br /><applet load="1k9g" size="450" color="white" frame="true" align="right" spinBox="true" caption="1k9g, resolution 1.4Å" /> '''Crystal Structure of ...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1k9g.gif|left|200px]]<br /><applet load="1k9g" size=" | + | [[Image:1k9g.gif|left|200px]]<br /><applet load="1k9g" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1k9g, resolution 1.4Å" /> | caption="1k9g, resolution 1.4Å" /> | ||
'''Crystal Structure of the Complex of Cryptolepine-d(CCTAGG)2'''<br /> | '''Crystal Structure of the Complex of Cryptolepine-d(CCTAGG)2'''<br /> | ||
==Overview== | ==Overview== | ||
| - | Cryptolepine, a naturally occurring indoloquinoline alkaloid used as an | + | Cryptolepine, a naturally occurring indoloquinoline alkaloid used as an antimalarial drug in Central and Western Africa, has been found to bind to DNA in a formerly unknown intercalation mode. Evidence from competition dialysis assays demonstrates that cryptolepine is able to bind CG-rich sequences containing nonalternating CC sites. Here we show that cryptolepine interacts with the CC sites of the DNA fragment d(CCTAGG)(2) in a base-stacking intercalation mode. This is the first DNA intercalator complex, from approximately 90 solved by X-ray crystallography, to bind a nonalternating (pyrimidine-pyrimidine) DNA sequence. The asymmetry of the drug induces a perfect stacking with the asymmetric site, allowing for the stability of the complex in the absence of hydrogen bonding interactions. The crystal structure of this antimalarial drug-DNA complex provides evidence for the first nonalternating intercalation and, as such, provides a basis for the design of new anticancer or antimalarial drugs. |
==About this Structure== | ==About this Structure== | ||
| - | 1K9G is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with DR1 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | + | 1K9G is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=DR1:'>DR1</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1K9G OCA]. |
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Aymami, J.]] | [[Category: Aymami, J.]] | ||
[[Category: Coll, M.]] | [[Category: Coll, M.]] | ||
| - | [[Category: Lisgarten, J | + | [[Category: Lisgarten, J N.]] |
[[Category: Portugal, J.]] | [[Category: Portugal, J.]] | ||
| - | [[Category: Wright, C | + | [[Category: Wright, C W.]] |
[[Category: DR1]] | [[Category: DR1]] | ||
[[Category: dna intercalator complex]] | [[Category: dna intercalator complex]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:31:34 2008'' |
Revision as of 11:31, 21 February 2008
|
Crystal Structure of the Complex of Cryptolepine-d(CCTAGG)2
Overview
Cryptolepine, a naturally occurring indoloquinoline alkaloid used as an antimalarial drug in Central and Western Africa, has been found to bind to DNA in a formerly unknown intercalation mode. Evidence from competition dialysis assays demonstrates that cryptolepine is able to bind CG-rich sequences containing nonalternating CC sites. Here we show that cryptolepine interacts with the CC sites of the DNA fragment d(CCTAGG)(2) in a base-stacking intercalation mode. This is the first DNA intercalator complex, from approximately 90 solved by X-ray crystallography, to bind a nonalternating (pyrimidine-pyrimidine) DNA sequence. The asymmetry of the drug induces a perfect stacking with the asymmetric site, allowing for the stability of the complex in the absence of hydrogen bonding interactions. The crystal structure of this antimalarial drug-DNA complex provides evidence for the first nonalternating intercalation and, as such, provides a basis for the design of new anticancer or antimalarial drugs.
About this Structure
1K9G is a Protein complex structure of sequences from [1] with as ligand. Full crystallographic information is available from OCA.
Reference
The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites., Lisgarten JN, Coll M, Portugal J, Wright CW, Aymami J, Nat Struct Biol. 2002 Jan;9(1):57-60. PMID:11731803
Page seeded by OCA on Thu Feb 21 13:31:34 2008
